Health insurance giant Aetna is funding a study of whether women who should be offered genetic screening tests for breast and ovarian cancer risk are indeed being offered the tests, reports the Wall Street Journal's Health Blog.
Health insurance giant Aetna is funding a study of whether women who should be offered genetic screening tests for breast and ovarian cancer risk are indeed being offered the tests, reports the Wall Street Journal's Health Blog.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.